Holowatz Lacy A, Jennings John D, Lang James A, Kenney W Larry
Department of Kinesiology, The Pennsylvania State University, Noll Laboratory,University Park, Pennsylvania, USA.
J Appl Physiol (1985). 2009 Oct;107(4):1121-7. doi: 10.1152/japplphysiol.00750.2009. Epub 2009 Aug 6.
In young healthy humans full expression of reflex cutaneous vasodilation is dependent on cyclooxygenase (COX)- and nitric oxide synthase (NOS)-dependent mechanisms. Chronic low-dose aspirin therapy attenuates reflex cutaneous vasodilation potentially through both platelet and vascular COX-dependent mechanisms. We hypothesized the contribution of COX-dependent vasodilators to reflex cutaneous vasodilation during localized acute COX inhibition would be attenuated in healthy middle-aged humans due to a shift toward COX-dependent vasoconstrictors. Four microdialysis fibers were placed in forearm skin of 13 middle-aged (53 +/- 2 yr) normotensive healthy humans, serving as control (Ringer), COX-inhibited (10 mM ketorolac), NOS-inhibited (10 mM N(G)-nitro-l-arginine methyl ester), and combined NOS- and COX-inhibited sites. Red blood cell flux was measured over each site by laser-Doppler flowmetry as reflex vasodilation was induced by increasing oral temperature (T(or)) 1.0 degrees C using a water-perfused suit. Cutaneous vascular conductance was calculated (CVC = flux/mean arterial pressure) and normalized to maximal CVC (CVC(max); 28 mM sodium nitroprusside). CVC(max) was not affected by localized microdialysis drug treatment (P > 0.05). Localized COX inhibition increased baseline (18 +/- 3%CVC(max); P < 0.001) compared with control (9 +/- 1%CVC(max)), NOS-inhibited (7 +/- 1%CVC(max)), and combined sites (10 +/- 1%CVC(max)). %CVC(max) in the COX-inhibited site remained greater than the control site with DeltaT(or) < or = 0.3 degrees C; however, there was no difference between these sites with DeltaT(or) > or = 0.4 degrees C. NOS inhibition and combined COX and NOS inhibition attenuated reflex vasodilation compared with control (P < 0.001), but there was no difference between these sites. Localized COX inhibition with ketorolac significantly augments baseline CVC but does not alter the subsequent skin blood flow response to hyperthermia, suggesting a limited role for COX-derived vasodilator prostanoids in reflex cutaneous vasodilation and a shift toward COX-derived vasoconstrictors in middle-aged human skin.
在年轻健康人群中,反射性皮肤血管舒张的充分表达依赖于环氧化酶(COX)和一氧化氮合酶(NOS)相关机制。慢性低剂量阿司匹林治疗可能通过血小板和血管COX相关机制减弱反射性皮肤血管舒张。我们推测,由于向COX依赖性血管收缩剂转变,在健康中年人群中,局部急性COX抑制期间COX依赖性血管舒张剂对反射性皮肤血管舒张的贡献会减弱。将四根微透析纤维置于13名中年(53±2岁)血压正常的健康人的前臂皮肤中,分别作为对照(林格液)、COX抑制组(10 mM酮咯酸)、NOS抑制组(10 mM N(G)-硝基-L-精氨酸甲酯)以及NOS和COX联合抑制组。当使用水灌注服使口腔温度(T(or))升高1.0℃诱导反射性血管舒张时,通过激光多普勒血流仪测量每个部位的红细胞通量。计算皮肤血管传导率(CVC = 通量/平均动脉压)并将其标准化为最大CVC(CVC(max);28 mM硝普钠)。CVC(max)不受局部微透析药物治疗的影响(P > 0.05)。与对照(9±1%CVC(max))、NOS抑制组(7±1%CVC(max))和联合抑制组(10±1%CVC(max))相比,局部COX抑制增加了基线水平(18±3%CVC(max);P < 0.001)。当ΔT(or)≤0.3℃时,COX抑制部位的%CVC(max)仍高于对照部位;然而,当ΔT(or)≥0.4℃时,这些部位之间没有差异。与对照相比,NOS抑制以及COX和NOS联合抑制减弱了反射性血管舒张(P < 0.001),但这些部位之间没有差异。用酮咯酸进行局部COX抑制可显著增加基线CVC,但不改变随后皮肤对热疗的血流反应,这表明COX衍生的血管舒张性前列腺素在反射性皮肤血管舒张中的作用有限,且中年人类皮肤向COX衍生的血管收缩剂转变。